Bruce Robinson, MD, MS, FASN, is Professor in Internal Medicine (Nephrology) at the University of Michigan (U-M) Medical School, as well as Associate Investigator, Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI. Dr. Robinson obtained his medical degree at the University of Michigan, and post-graduate training in nephrology and an MS in Clinical Epidemiology at the University of Pennsylvania. Before transitioning in April 2023 to full-time faculty at U-M, he was Vice President for Clinical Research at Arbor Research Collaborative for Health, a non-profit research company, from 2007-2022, and Scientific Director of the Dialysis Outcomes and Practice Patterns Study (DOPPS) Program from 2009-2022. The DOPPS Program includes a longstanding international hemodialysis cohort study (DOPPS, since 1996), and studies launched in 2012-13, under his leadership, in peritoneal dialysis (PDOPPS) and advanced chronic kidney disease (CKDopps). As of late 2022, these studies together were active in 19 countries and over 750 clinical sites, supported by a large consortium of industry funders and government-funded ancillary studies in the US and internationally. Dr. Robinson was Co-Principal Investigator from 2013-2024 of the Data Coordinating Center (DCC) for Cure Glomerulonephopathy (CureGN), an NIH/NIDDK-funded (U01/U24) multi-center observational study of patients with glomerular disease, and he was Co-Deputy Director from 2014-2019 of the Coordinating Center for the United States Renal Data System (USRDS), a state-of-the art NIH/NIDDK-funded registry. He has research expertise in the epidemiology of kidney disease, quantitative analysis for studies of patients with advanced CKD and kidney failure, and pragmatic trials in CKD. He has a long record leading projects that provide RWD support for clinical development and post-approval needs in kidney therapeutics.